鉴定和验证与慢性阻塞性肺病中线粒细胞衰变相关的生物标志物
Jie Chen1, Xiaofeng Zhang2, Gengyun Sun1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
Molecular medicine reports
|February 14, 2025
概括
这项研究确定了线粒体转录终止因子3 (MTERF3) 作为慢性阻塞性肺病 (COPD) 中关键的线粒体转录相关基因. MTERF3显示了诊断潜力,并影响了COPD中的髓,提供了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 线在慢性阻塞性肺病 (COPD) 病原发生过程中至关重要.
- 识别特定的菌相关基因对于了解COPD至关重要.
- 需要生物信息和实验方法来验证COPD中的基因作用.
研究的目的:
- 选和验证与COPD相关的菌体相关基因.
- 为了确定COPD的诊断生物标志物.
- 调查已识别的基因在COPD中菌调节中的作用.
主要方法:
- 利用基因表达总量数据集进行生物信息分析.
- 使用了威尔科克森测试,基因本体学,KEGG,LASSO回归和ROC分析.
- 用香烟烟雾提取物 (CSE) 处理的支气管上皮细胞中的验证结果.
主要成果:
- 在COPD中鉴定出14个差异表达的菌相关基因 (DEMRGs).
- 线粒体转录终止因子3 (MTERF3) 被确定为一个重要的诊断基因.
- 在实验室中,MTERF3表达与免疫细胞透相关,并促进了线粒.
结论:
- MTERF3是一种与COPD相关的新型线粒相关基因.
- MTERF3有可能成为COPD的诊断生物标志物.
- 向MTERF3可能为COPD提供新的治疗策略.
更多相关视频
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K